Parschauer Karah Herdman

Parschauer Karah Herdman is listed in filings as Director at Tenaya Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 29, 2026, including sale activity. Recent filings connect the profile to Tenaya Therapeutics, Inc. (TNYA), Ultragenyx Pharmaceutical Inc (RARE), and Evolus, Inc. (EOLS). The current snapshot covers public activity from Jun 12, 2024 to May 29, 2026. Reported amounts are shown as $95.9K to $79.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.